{"id":"NCT01680341","sponsor":"Novo Nordisk A/S","briefTitle":"Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine","officialTitle":"A Trial Comparing the Efficacy and Safety of Two Different Titration Algorithms for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine (BOOST®: SIMPLE vs. STEPWISE)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-08-31","primaryCompletion":"2013-08-22","completion":"2013-08-22","firstPosted":"2012-09-07","resultsPosted":"2015-11-17","lastUpdate":"2018-04-02"},"enrollment":272,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"insulin degludec/insulin aspart","otherNames":["IDegAsp"]},{"type":"DRUG","name":"insulin degludec/insulin aspart","otherNames":["IDegAsp"]}],"arms":[{"label":"IDegAsp Simple","type":"EXPERIMENTAL"},{"label":"IDegAsp Step wise","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in Africa, Asia, Europe and the United States of America (USA).\n\nThe aim of the trial is to compare the efficacy and safety of two different titration algorithms for insulin degludec/insulin aspart (IDeg/IAsp) in subjects with type 2 diabetes mellitus previously treated with insulin glargine.","primaryOutcome":{"measure":"Change From Baseline in HbA1c (Glycosylated Haemoglobin) (%)","timeFrame":"Week 0, Week 26","effectByArm":[{"arm":"IDegAsp Simple","deltaMin":-1.45,"sd":0.09},{"arm":"IDegAsp Step Wise","deltaMin":-1.33,"sd":0.09}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":45,"countries":["United States","Algeria","Germany","Malaysia","Turkey (Türkiye)"]},"refs":{"pmids":["23710902","29451706","35044568","26720250"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":135},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Influenza","Headache","Back pain"]}}